Isotretinoin for acne and rosacea

Kendra D. Watson, Rachel Y. Miest, Megha M. Tollefson

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Isotretinoin is a revolutionary medicine for the treatment of acne vulgaris, with new studies showing evidence of excellent clinical outcomes in treating rosacea. After 30 years of clinical experience, new insights are being gained into dosing strategies, recurrence prevention, and dose-related side effects. Previous controversial associations with inflammatory bowel diseases and mood disorders have hampered the use of this medication in some clinical situations, with new evidence disproving these claims. The teratogenicity of this medication mandates iPLEDGE compliance with government regulations. Clinicians should be knowledgeable about this medication including its side effects, teratogenicity, and its controversies in order to adequately counsel patients, dissuade fears, and obtain the best clinical outcome when treating acne and rosacea.

Original languageEnglish (US)
Pages (from-to)79-86
Number of pages8
JournalSeminars in Cutaneous Medicine and Surgery
Volume35
Issue number2
DOIs
StatePublished - Jun 1 2016

ASJC Scopus subject areas

  • Surgery
  • Medicine(all)
  • Dermatology

Fingerprint Dive into the research topics of 'Isotretinoin for acne and rosacea'. Together they form a unique fingerprint.

  • Cite this